Study guide

8.5 Management of Common Discomforts & Physiologic Changes in Pregnancy

WHNP-BC Women's Health Nurse Practitioner Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction: About the WHNP-BC Exam

WHNP-BC Exam Facts, Blueprint & Study Plan

2 Chapter 1: Well-Woman Care, Assessment & Gynecologic Screening

1.1 Well-Woman Health Maintenance & Routine Screening Across the Lifespan 1.2 Comprehensive Health History & Physical Examination (Female and Male) 1.3 Cervical Cancer Screening & ASCCP Risk-Based Management Guidelines 1.4 Breast Health Assessment, Diagnostic Imaging & Breast Cancer Screening

3 Chapter 2: Vulvovaginal Infections, STIs & HIV Prevention

2.1 Vulvovaginitis: Bacterial Vaginosis, Candidiasis & Trichomoniasis 2.2 Sexually Transmitted Infections: Chlamydia, Gonorrhea, Syphilis & Pelvic Inflammatory Disease 2.3 Viral STIs & Chronic Vulvar Dermatoses (HSV, HPV, Lichen Sclerosus & Lichen Planus) 2.4 HIV Prevention (PrEP & PEP), Viral Hepatitis, Mycoplasma genitalium & Ectoparasites

4 Chapter 3: Gynecologic Disorders, Pelvic Pain & Gynecologic Cancers

3.1 Abnormal Uterine Bleeding & the FIGO PALM-COEIN Classification 3.2 Uterine Leiomyomas, Adenomyosis & Endometrial and Cervical Polyps 3.3 Dysmenorrhea, Endometriosis & Chronic Pelvic Pain Management 3.4 Benign Pelvic Masses, Pelvic Organ Prolapse & Urinary Incontinence 3.5 Gynecologic Malignancies: Endometrial, Ovarian, Cervical, Vulvar & Vaginal Cancers

5 Chapter 4: Reproductive Physiology, Endocrinology & Infertility

4.1 Reproductive Anatomy, Puberty, the Menstrual Cycle & Müllerian Anomalies 4.2 Polycystic Ovary Syndrome (PCOS) & Hyperandrogenic Disorders 4.3 Amenorrhea Evaluation: Primary & Secondary Etiologies 4.4 Infertility Workup, Ovulation Induction & Assisted Reproductive Technologies

6 Chapter 5: Contraception, Family Planning & Unintended Pregnancy

5.1 Long-Acting Reversible Contraception (LARC): IUDs & Subdermal Implants 5.2 Hormonal Contraceptives: Combined & Progestin-Only Methods 5.3 Emergency Contraception, Barrier Methods & Fertility Awareness-Based Methods 5.4 CDC U.S. Medical Eligibility Criteria (US MEC) & Permanent Sterilization 5.5 Unintended Pregnancy: Options Counseling, Medication & Procedural Abortion

7 Chapter 6: Perimenopause, Menopause & Postmenopausal Health

6.1 Menopausal Transition Physiology, Vasomotor Symptoms & Clinical Staging (STRAW+10) 6.2 Menopausal Hormone Therapy (MHT): Indications, Regimens & Contraindications 6.3 Genitourinary Syndrome of Menopause (GSM) & Postmenopausal Osteoporosis

8 Chapter 7: Sexual Health, Male Reproductive Health & LGBTQ+ Care

7.1 Female Sexual Function, Sexual Dysfunction & LGBTQ+ Sexual Health 7.2 Male Sexual & Reproductive Health: STIs, Infertility, Contraception & Sexual Dysfunction

9 Chapter 8: Preconception, Fetal Development & Normal Antepartum Care

8.1 Preconception Counseling, Risk Assessment & Teratogen Exposure 8.2 Early Pregnancy Diagnosis, Gestational Dating & Initial Prenatal Evaluation 8.3 Embryonic & Fetal Development, the Placenta, Fetal Circulation & Amniotic Fluid 8.4 Routine Antepartum Surveillance, Nutritional Needs & Weight Gain Guidelines 8.5 Management of Common Discomforts & Physiologic Changes in Pregnancy

10 Chapter 9: Antepartum Complications I: Hypertension, Diabetes, Bleeding & Preterm Birth

9.1 Hypertensive Disorders of Pregnancy & Preeclampsia Management 9.2 Gestational Diabetes Mellitus: Screening, Glycemic Targets & Management 9.3 Bleeding in Pregnancy: Spontaneous Abortion, Ectopic Pregnancy & Placental Disorders 9.4 Preterm Labor, PPROM & Cervical Insufficiency

11 Chapter 10: Antepartum Complications II: Infections, Medical Disorders & Fetal Conditions

10.1 Infections in Pregnancy: CMV, Parvovirus, Varicella, Rubella, Toxoplasmosis, Listeria, GBS & HIV 10.2 Maternal Medical Disorders in Pregnancy: Pregestational Diabetes, Epilepsy, Thrombocytopenia, Obesity & Cardiac Disease 10.3 Gestational Trophoblastic Disease, Recurrent Loss, Stillbirth & Perinatal Bereavement 10.4 Multiple Gestation, Fetal Growth Disorders, Amniotic Fluid Abnormalities, Malpresentation & Postterm Pregnancy 10.5 Rh(D) Alloimmunization & Hemolytic Disease of the Fetus and Newborn

12 Chapter 11: Intrapartum Principles & Fetal Surveillance

11.1 Electronic Fetal Monitoring (EFM): Baseline, Variability, Decelerations & Categories 11.2 Labor Assessment, Stages of Labor & Labor Dystocia 11.3 Trial of Labor After Cesarean (TOLAC) & Intrapartum Emergencies

13 Chapter 12: Postpartum Management, Lactation & Puerperal Complications

12.1 Postpartum Involution, Physical Recovery & Routine Puerperal Care 12.2 Postpartum Hemorrhage: The 4 Ts, Uterotonic Pharmacotherapy & Emergency Protocols 12.3 Puerperal Infections & Postpartum Mood Disorders 12.4 Physiology of Lactation, Common Breastfeeding Challenges & Infant Feeding 12.5 Other Puerperal Complications: Hematomas, Urinary Retention, Hemorrhoids, Postpartum Hypertension & Warning Signs

14 Chapter 13: Primary Care: Cardiovascular, Thromboembolic, Respiratory & HEENT Conditions

13.1 Hypertension & Cardiovascular Disease in Women: Gender-Specific Presentations 13.2 Dyslipidemia & ASCVD Risk: The 2026 ACC/AHA Guideline 13.3 Venous Thromboembolism in Women: Risk, Diagnosis, Treatment & Prevention in Pregnancy 13.4 Respiratory Conditions in Women: Asthma Management & Respiratory Infections 13.5 HEENT & Upper Respiratory Conditions: Conjunctivitis, Rhinitis, Pharyngitis, Sinusitis, Otitis & the Common Cold

15 Chapter 14: Primary Care: Endocrine, Metabolic & Gastrointestinal Disorders

14.1 Type 2 Diabetes Mellitus & Metabolic Syndrome in Women 14.2 Obesity, Weight Management & Healthy Lifestyle Counseling 14.3 Thyroid Disorders: Hypothyroidism, Hyperthyroidism & Postpartum Thyroiditis 14.4 Gastrointestinal Conditions: GERD, Irritable Bowel Syndrome & Gallbladder Disease 14.5 Constipation, Hemorrhoids, Peptic Ulcer Disease & Other Upper and Lower GI Disorders

16 Chapter 15: Primary Care: Renal, Hematologic, Rheumatologic, Musculoskeletal & Dermatologic Health

15.1 Urinary Tract Infections, Pyelonephritis, Hematuria & Nephrolithiasis 15.2 Anemias in Women: Iron Deficiency, Microcytic & Macrocytic Anemias 15.3 Autoimmune & Rheumatologic Conditions: SLE, Antiphospholipid Syndrome, RA & Fibromyalgia 15.4 Musculoskeletal Complaints: Low Back Pain, Osteoarthritis, Sprains, Strains & Common Conditions in Women 15.5 Common Dermatologic Disorders in Women Across the Lifespan 15.6 Common Skin Conditions: Eczema, Contact Dermatitis, Psoriasis, Tinea, Vitiligo, Skin Lesions & Hidradenitis

17 Chapter 16: Neurologic, Mental Health, Behavioral & Psychosocial Care

16.1 Headache Disorders in Women: Migraine, Tension-Type, Red Flags & Hormonal Considerations 16.2 Depressive Disorders & Anxiety in Women Across the Reproductive Lifespan 16.3 Substance Use Disorders: Alcohol, Nicotine, Cannabis & Opioid Use in Women 16.4 Intimate Partner Violence (IPV), Sexual Assault & Trauma-Informed Care

18 Chapter 17: Assessment, Diagnostic Testing & Interpretation

17.1 Laboratory Diagnostics: Hematology, Coagulation, Chemistry, Hormone, Serologic & Screening Tests 17.2 Genetic Principles: Inheritance Patterns, Carrier Screening & Hereditary Cancer Risk Assessment 17.3 Gynecologic Office Diagnostic Procedures: Wet Mounts, Endometrial Biopsy & Colposcopy 17.4 Obstetric Diagnostic Imaging & Genetic Screening Modalities

19 Chapter 18: Pharmacology: Pharmacokinetics, Pharmacodynamics, Pharmacogenetics & Safe Prescribing

18.1 Clinical Pharmacokinetics Across the Female Lifespan & the FDA PLLR 18.2 Pharmacodynamics, Pharmacogenetics & Clinically Important Drug Interactions in Women's Health 18.3 Antimicrobial Stewardship & Pharmacotherapy in Pregnancy and Lactation

20 Chapter 19: Professional Role, Legal, Ethical, Quality & Health Equity Responsibilities

19.1 APRN Scope of Practice, Consensus Model & Collaborative Practice 19.2 Legal, Ethical & Informed Consent Issues in Reproductive Health Care 19.3 Evidence-Based Practice, Research Terminology, Quality Improvement & Patient Safety 19.4 Maternal Health Equity, Cultural Humility & Gender-Affirming Gynecologic Care

8.5 Management of Common Discomforts & Physiologic Changes in Pregnancy

Key Takeaways Explain This Topic AI

Maternal cardiovascular adaptations include a 40–50% expansion in plasma volume, physiological hemodilution ('physiologic anemia of pregnancy' with Hb nadir ~10.5 g/dL), a 30–50% increase in cardiac output, and decreased systemic vascular resistance causing blood pressure to nadir mid-second trimester.

Progesterone-mediated stimulation of central respiratory drive increases tidal volume by 30–40% and minute ventilation, creating a mild chronic compensated respiratory alkalosis (PaCO2 27–32 mmHg, HCO3 18–22 mEq/L) that enhances transplacental carbon dioxide diffusion.

Renal blood flow and GFR increase by 50%, resulting in lower normal serum creatinine (0.4–0.6 mg/dL); a serum creatinine ≥0.8 mg/dL is abnormal in pregnancy and warrants investigation for renal insufficiency.

First-line pharmacotherapy for nausea and vomiting of pregnancy (NVP) refractory to dietary adjustments is pyridoxine (vitamin B6, 10–25 mg) alone or combined with doxylamine succinate (10–12.5 mg); hyperemesis gravidarum requiring intravenous dextrose mandates prior or concurrent IV thiamine (vitamin B1) administration to prevent Wernicke encephalopathy.

Common pregnancy discomforts (gastroesophageal reflux, round ligament pain, physiologic leukorrhea, and lumbar lordosis) stem from hormonal and anatomical adaptations; management emphasizes non-pharmacologic measures, safe stepwise pharmacology, and differentiation from acute obstetric pathologies.

Last updated: October 2026

Maternal Systemic Physiological Adaptations

Pregnancy triggers profound, coordinated anatomical and endocrinological alterations across every maternal organ system. These adaptations support the metabolic demands of the growing fetoplacental unit and protect against intrapartum blood loss.

Cardiovascular Adaptations

Plasma Volume & Hemodilution: Maternal plasma volume expands by 40% to 50% (~1,200 to 1,500 mL) above non-pregnant baselines. In contrast, erythrocyte mass increases by only 20% to 30% (~300 to 450 mL) via erythropoietin stimulation. This marked disparity produces physiological hemodilution ("physiologic anemia of pregnancy") , where hematocrit declines to ~32% to 34% and hemoglobin reaches a nadir of 10.5 to 11.0 g/dL late in the second trimester.

Cardiac Output (CO): Increases by 30% to 50% . Early in pregnancy, this rise is driven primarily by increased stroke volume (SV) (+25% to 30%). Later in gestation, maternal heart rate increases by 10 to 15 beats per minute , sustaining elevated cardiac output.

Systemic Vascular Resistance (SVR) & Blood Pressure: High circulating levels of progesterone, prostacyclin (PGI₂), and nitric oxide induce vascular smooth muscle relaxation, dramatically lowering SVR. Blood pressure declines early in pregnancy, reaching a nadir at 24 to 28 weeks (systolic drops 5–10 mmHg, diastolic drops 10–15 mmHg), before gradually returning to pre-pregnancy baselines by term.

Auscultatory Findings: A physiologic grade I–II/VI systolic ejection murmur heard along the left sternal border is present in >90% of pregnant women due to hyperdynamic flow across the aortic and pulmonic valves. An S3 gallop is common. In contrast, diastolic murmurs are ALWAYS pathologic and mandate formal echocardiography.

Supine Hypotensive Syndrome: In late gestation, the gravid uterus compresses the inferior vena cava (IVC) and descending aorta when the patient is in the supine position. This impedes venous return to the right atrium, precipitating sudden drops in cardiac output, arterial hypotension, syncope, and reduced uteroplacental perfusion. It is promptly corrected by repositioning the patient in the left lateral tilt position .

Respiratory Adaptations

Progesterone & Hyperventilation: Progesterone acts directly on the hypothalamic respiratory center, lowering the threshold and increasing central sensitivity to carbon dioxide.

Ventilatory Mechanics: Tidal volume (TV) increases by 30% to 40% without a significant change in respiratory rate, driving a 30% to 50% increase in minute ventilation . Vital capacity remains unchanged, while functional residual capacity (FRC) and residual volume decline by 20% due to diaphragmatic elevation by the gravid uterus.

Acid-Base Homeostasis: Maternal hyperventilation produces a state of chronic compensated respiratory alkalosis :

  • Arterial pH: 7.40 to 7.45
  • Arterial PaCO₂: 27 to 32 mmHg (non-pregnant baseline: 35 to 45 mmHg)

Serum Bicarbonate (HCO₃⁻): 18 to 22 mEq/L (non-pregnant baseline: 22 to 26 mEq/L) via compensatory renal excretion.

This lowered maternal PaCO₂ creates a favorable maternal-fetal gradient that facilitates passive transplacental diffusion of fetal carbon dioxide into maternal blood.

Dyspnea of Pregnancy: Experienced by up to 60% to 70% of healthy pregnant women, dyspnea reflects central awareness of hyperventilation rather than cardiopulmonary compromise.

Renal & Urinary Adaptations

Renal Hemodynamics: Renal blood flow (RBF) and Glomerular Filtration Rate (GFR) increase by ~50% beginning in early pregnancy, driven by relaxin and nitric oxide.

Solute Excretion & Laboratory Baselines: Elevated GFR accelerates the clearance of urea and creatinine. Consequently, normal pregnancy serum baselines are significantly lower than non-pregnant values:

Normal pregnancy Serum Creatinine: 0.4 to 0.6 mg/dL (non-pregnant: 0.7 to 1.2 mg/dL).

Normal pregnancy BUN: 8 to 10 mg/dL .

A serum creatinine ≥0.8 mg/dL is abnormal in pregnancy and reflects underlying renal impairment!

Physiologic Hydronephrosis: Dilation of the renal calyces, pelves, and ureters occurs in >80% of gravidas. Dilation is markedly more pronounced on the right side than the left , resulting from dextrorotation of the enlarging uterus and compression of the right ureter as it crosses the iliac vessels adjacent to the dilated right ovarian vein complex.

Gastrointestinal Adaptations

Smooth Muscle Relaxation: Progesterone relaxes smooth muscle throughout the alimentary tract, causing decreased lower esophageal sphincter (LES) tone (predisposing to pyrosis), delayed gastric emptying, and prolonged colonic transit time with increased water absorption (predisposing to constipation).

Biliary Stasis: Impaired gallbladder motility and incomplete emptying promote biliary sludge and gallstone formation, increasing the risk of cholelithiasis and intrahepatic cholestasis of pregnancy.

Normal Physiologic Shifts vs. Pathologic Findings

Organ System Normal Physiological Adaptation Pathological Finding Warranting Diagnostic Workup

Cardiovascular Grade I–II systolic murmur, S3 gallop, resting HR increase of 10–15 bpm, physiologic hemodilution (Hb ≥10.5 g/dL). Any diastolic murmur, new holosystolic murmur, chest pain, syncope not relieved by left lateral tilt, severe anemia (Hb <10.0 g/dL).

Respiratory Chronic compensated respiratory alkalosis (PaCO₂ 27–32 mmHg, HCO₃⁻ 18–22 mEq/L), mild dyspnea at rest. Tachypnea (>24/min), hypoxemia (SpO₂ <95%), hemoptysis, wheezing, productive cough, pleuritic chest pain.

Renal Serum creatinine 0.4–0.6 mg/dL, BUN 8–10 mg/dL, asymptomatic right-sided hydronephrosis. Serum creatinine ≥0.8 mg/dL, macroalbuminuria, flank pain with costovertebral tenderness, pyuria with fever.

Gastrointestinal Mild pyrosis, bloating, constipation, nausea resolving by 16–20 weeks without weight loss. Intractable vomiting with >5% weight loss, ketonuria, hematemesis, severe epigastric/RUQ pain, jaundice, pruritus of palms/soles.

  • Stepwise Management of Common Pregnancy Discomforts
  • 1. Nausea & Vomiting of Pregnancy (NVP) & Hyperemesis Gravidarum

NVP affects 70% to 80% of pregnant individuals. Symptoms peak between 8 and 12 weeks of gestation and typically resolve by 16 to 20 weeks.

Non-Pharmacologic Foundations

Frequent, small-volume meals (every 1 to 2 hours) high in protein and complex carbohydrates; avoid an empty stomach.

Keep plain crackers at the bedside to eat 15 minutes before getting out of bed.

Separate dry foods from liquids by at least 30 minutes; drink cold, clear carbonated fluids.

Avoid strong food odors, spicy/greasy foods, and flickering lights.

P6 acupressure wristbands; ginger (capsules 250 mg orally four times daily, or ginger tea/chews).

Stepwise Pharmacotherapy Ladder (ACOG Guidelines)

First-Line Pharmacotherapy:

Pyridoxine (Vitamin B6): 10 to 25 mg orally 3 to 4 times daily, ALONE or COMBINED WITH

Doxylamine Succinate: 10 to 12.5 mg orally 3 to 4 times daily.

Formulations: Available as FDA-approved prescription fixed combinations (Diclegis: 10 mg/10 mg up to 4 tabs/day; Bonjesta: 20 mg/20 mg) or over-the-counter equivalents.

Second-Line Pharmacotherapy:

Add an oral or rectal H₁-receptor antagonist: Dimenhydrinate (25 to 50 mg PO/PR q4–6h) or Diphenhydramine (25 to 50 mg PO/IV q4–6h).

Add an oral/rectal dopamine antagonist: Promethazine (12.5 to 25 mg PO/PR/IM q4–6h) or Metoclopramide (5 to 10 mg PO/IV/IM q8h).

Third-Line Pharmacotherapy:

Serotonin 5-HT₃ receptor antagonists: Ondansetron (4 to 8 mg PO/IV q8h).

Safety Note: Reserve ondansetron for refractory symptoms and exercise caution prior to 10 weeks of gestation due to a small potential risk of cleft palate, and monitor for maternal QT interval prolongation.

Hyperemesis Gravidarum (HG) & Thiamine Mandate

Hyperemesis gravidarum is characterized by severe, intractable vomiting, dehydration, ketonuria, electrolyte derangements (hypokalemia, hypochloremia, metabolic alkalosis), and weight loss exceeding 5% of pre-pregnancy weight .

Inpatient Fluid Resuscitation: Intravenous replacement with normal saline or lactated Ringer's containing potassium chloride.

THE CRITICAL THIAMINE MANDATE: Intravenous Thiamine (Vitamin B1, 100 mg) MUST be administered prior to or concurrently with any intravenous dextrose-containing infusion .

Important

Administering intravenous dextrose solutions to a malnourished, vomiting pregnant patient without thiamine induces acute consumption of remaining thiamine stores during glycolysis, precipitating irreversible Wernicke Encephalopathy (the clinical triad of acute confusion/encephalopathy, ataxia, and ophthalmoplegia/nystagmus). Always administer IV thiamine 100 mg daily for 2 to 3 days before starting dextrose infusions in patients with hyperemesis gravidarum.

2. Gastroesophageal Reflux Disease (Pyrosis / Heartburn)

Pyrosis affects up to 80% of pregnant individuals due to progesterone-mediated lower esophageal sphincter (LES) relaxation and mechanical displacement by the expanding uterus.

Lifestyle Modifications: Small, frequent meals; avoid eating within 2 to 3 hours of recumbency; elevate head of bed 6 inches; avoid caffeine, chocolate, peppermint, citrus, tomatoes, and fried foods.

Step 1: Antacids: Calcium carbonate (Tums) is preferred. Avoid sodium bicarbonate (causes maternal/fetal metabolic alkalosis and fluid overload) and avoid magnesium trisilicate (fetal nephrotoxicity).

Step 2: Histamine-2 Receptor Antagonists (H₂RAs): Oral Famotidine (20 to 40 mg daily) is safe and effective.

Step 3: Proton Pump Inhibitors (PPIs): Oral Omeprazole (20 mg daily) or pantoprazole for refractory, erosive symptoms.

3. Round Ligament Pain

Sharp, jabbing, or dull aching unilateral or bilateral lower abdominal/groin pain radiating into the labia, occurring between 16 and 24 weeks of gestation.

Etiology: Spasm and mechanical stretching of the fibromuscular round ligaments as the enlarging uterus ascends out of the pelvis and rotates.

Management: Reassurance; avoid rapid postural shifts; flex hips toward abdomen when coughing or sneezing; apply local warmth (warm bath or warm compress on low heat); prenatal pelvic tilt exercises; wear a supportive maternity abdominal support belt; oral acetaminophen as needed.

4. Physiologic Leukorrhea vs. Vaginal Infection

Profuse, thin, white/clear, odorless, non-irritating vaginal discharge resulting from high estrogen-driven vaginal epithelial hyperplasia and increased cervical glandular mucus.

Evaluation: Absence of pruritus, burning, erythema, or malodor. Wet mount reveals normal superficial squamous cells and abundant lactobacilli without clue cells, fungal hyphae, or motile trichomonads. Vaginal pH is normally acidic (<4.5).

Management: Reassurance; wear breathable cotton underwear; use unscented panty liners. Strictly counsel against douching, internal vaginal washes, and scented hygiene products , which destroy protective Lactobacillus species and elevate risks of bacterial vaginosis and ascending infection.

5. Lumbar Lordosis & Lower Back Pain

Forward uterine growth shifts the maternal center of gravity anteriorly over the lower extremities, compensated by exaggerated lumbar lordosis, paraspinal muscle strain, and relaxin-induced sacroiliac joint laxity.

Management: Maintain proper ergonomics (lift with knees, not back); avoid high-heeled shoes; sleep in lateral decubitus with a pillow between knees; pelvic tilt and core-strengthening exercises; maternal support belt; physical therapy; local heat/ice; acetaminophen.